Kedrion alongside the World Hepatitis Alliance

On the occasion of World Hepatitis Day on 28 July, the World Hepatitis Alliance (WHA) has just launched a white paper outlining the human impact of mother-to-child transmission of hepatitis B. Kedrion is proud to support WHA’s programme aimed at preventing mother-to-child transmission (PMTCT) of hepatitis B, with an unconditional educational grant.

WHA’s white paper ‘Mothers and babies can’t wait – A call for action to end mother-to-child transmission of hepatitis B’, highlights that 1.5 million (1.1 million-2.6 million) people newly acquired hepatitis B in 2019 [1]. Most of these were as a result of mother-to-child transmission. 

A safe and effective vaccine for hepatitis B has been available for over four decades, but many countries have not yet harnessed its power effectively. More than half of infants worldwide still do not have access to the hepatitis B birth dose vaccine. 

The white paper includes recommendations which could ensure that the prevention of mother to child transmission is equitable, accessible, and available to all who need them, when carried out in conjunction with established guidelines.

Click here to learn more: 

Source [1]: World Health Organization, 2021a. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Available at: Accessed 15 July 2022 

For more information please contact: [email protected]